3.0.0 1950 2025-07-21T19:32:26Z 2025-07-21T19:32:26Z Senate S S 2023-06-13 118 ssju00 Judiciary Committee Senate Standing Referred To 2023-06-13T20:44:32Z 2023-06-13 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2023-06-13 Introduced in Senate IntroReferral 10000 9 Library of Congress B001288 Sen. Booker, Cory A. [D-NJ] Cory Booker D NJ N W000800 Sen. Welch, Peter [D-VT] Peter Welch D VT 2023-09-12 False M000133 Sen. Markey, Edward J. [D-MA] Edward Markey D MA J. 2023-10-31 False W000817 Sen. Warren, Elizabeth [D-MA] Elizabeth Warren D MA A. 2023-12-12 False H001042 Sen. Hirono, Mazie K. [D-HI] Mazie Hirono D HI K. 2024-01-17 False W000779 Sen. Wyden, Ron [D-OR] Ron Wyden D OR 2024-04-16 False P000145 Sen. Padilla, Alex [D-CA] Alex Padilla D CA 2024-04-16 False B001320 Sen. Butler, Laphonza R. [D-CA] Laphonza Butler D CA 2024-05-21 False M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2024-06-05 False Crime and Law Enforcement Crime and Law Enforcement 2023-07-11T18:30:29Z

00 2023-06-13 Introduced in Senate 2024-06-24T19:39:12Z <p><strong>Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2023 or the TEST Act&nbsp;</strong></p><p>This bill provides for the rescheduling or removal from scheduling of certain fentanyl-related substances under the Controlled Substances Act.</p><p>Specifically, the bill requires the Drug Enforcement Administration (DEA) to schedule, reschedule, or remove from scheduling fentanyl-related substances it has identified but not yet permanently scheduled within one year of the bill's enactment. The DEA must schedule, reschedule, or remove from scheduling any new fentanyl-related substances that it identifies after the bill's enactment within three years of identification. The DEA may temporarily schedule newly identified fentanyl-related substances under schedule I for up to three years.&nbsp; The bill provides for the rescheduling of fentanyl-related substances to lower schedules, or for their removal from scheduling altogether, based on appropriate scientific and medical evaluations from the Department of Health and Human Services.&nbsp;</p><p>The bill also provides for expedited registrations to research schedule I controlled substances, including by allowing for the continuation and consolidation of research under a single registration.&nbsp;</p>

Display Title 45 2024-07-24T15:21:41Z Short Title(s) as Introduced 101 2024-05-24T13:38:56Z Introduced in Senate IS Short Title(s) as Introduced 101 2024-05-24T13:38:56Z Introduced in Senate IS Official Title as Introduced 6 2024-04-17T10:56:45Z Introduced in Senate IS Introduced in Senate 2023-06-13T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s1950is/xml/BILLS-118s1950is.xml 2023-06-13 Read twice and referred to the Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.